A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

NCT00236574 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

NCT00261573 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type

NCT00216515 ·Status: COMPLETED ·Phase: PHASE4

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation

NCT00253214 ·Status: COMPLETED ·Phase: PHASE3

A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

NCT00240695 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

NCT00253227 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.

NCT00301574 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Galantamine in the Treatment of Alzheimer's Disease

NCT00000172 ·Status: COMPLETED ·Phase: PHASE3

Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine

NCT01009476 ·Status: COMPLETED

A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

NCT00679627 ·Status: TERMINATED ·Phase: PHASE3

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

NCT00299676 ·Status: COMPLETED

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

NCT01054976 ·Status: COMPLETED ·Phase: PHASE4

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

NCT00304629 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

NCT00814801 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

NCT00082602 ·Status: COMPLETED ·Phase: PHASE3

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

NCT00416169 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

NCT00035191 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

NCT00645190 ·Status: COMPLETED ·Phase: PHASE3

Characteristics of Treatment Responders to Galantamine

NCT01029132 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease

NCT00338117 ·Status: COMPLETED ·Phase: PHASE3

The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life

NCT00814658 ·Status: COMPLETED ·Phase: PHASE4

A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.

NCT00309725 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

NCT01478633 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

NCT01921972 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

NCT00035204 ·Status: COMPLETED ·Phase: PHASE4